Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 19
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 15, 2026 | AdvanCell Closes US $315M in Series D Funding | AdvanCell, a Boston, MA- and Brisbane, Australia-based clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, raised US $315M Series D in funding. The round was led by Ally Bridge Group and Alpha Wave, al... |
| Jun 23, 2025 | Commons Clinic: $26 Million Series B Raised For Wholebody Multi-Specialty Care Platform | Commons Clinic announced a $26 million Series B financing, bringing the total funding to over $60 million. The funding round was led by RA Capital, with participation from Floating Point, SteelSky Ventures, Time BioVentures, Courtside Ventu... |
| Jun 13, 2025 | Commons Clinic Secures $26M to Revolutionize Preventative Healthcare | In a world where healthcare often feels fragmented, Commons Clinic is stitching together a cohesive fabric of care. The Los Angeles-based company recently secured $26 million in Series B funding, pushing its total capital to over $60 millio... |
| Jun 12, 2025 | Commons Clinic Secures $26M to Launch “Wholebody” Preventative Care Program | What You Should Know: – Commons Clinic today announced a $26M Series B financing, bringing its total funding to over $60M led by RA Capital, with participation from Floating Point, SteelSky Ventures, Time BioVentures, Courtside Ventures, an... |
| Mar 26, 2024 | Brightside Health Secures $33M to Expand Access to Mental Healthcare | What You Should Know: – Brightside Health, a teletherapy provider for depression, anxiety, and other mood disorders, raises $33M in Series C funding led by S32. – The funding round, which included participation from existing investors along... |
| Dec 12, 2022 | Kling Biotherapeutics Appoints Michael Koslowski, M.D. As Chief Executive Officer | AMSTERDAM, Dec. 12, 2022 /PRNewswire/ -- Kling Biotherapeutics, B.V., a clinical-stage company pioneering the discovery and development of novel antibody-based therapeutics, today announced the appointment of Michael Koslowski, M.D. as CEO.... |
| Oct 31, 2022 | Time BioVentures Launches $100M Fund | |
| Oct 27, 2022 | Time BioVentures Launches Biotech Fund | Time BioVentures, a Los Angeles, CA-based early-stage life sciences venture firm, closed its first Fund, with $100m AUM. Backed by a roster of biotech and healthcare luminaries, Time BioVentures I, LP, will finance innovations in medicine. ... |
| How Jellysmack’s New Production Studio Is Set Up To Help Creators Avoid Burnout | Creator economy startup Jellysmack is rounding out its offerings for content creators with its new original content division, JellySmash Productions. Having piloted the program for a year, JellySmash is officially launching with 12 creators... |
Reviews 0
FAQ about Time BioVentures
When was Time BioVentures founded?
Time BioVentures was founded in 2020.
What has the press written about Time BioVentures?
Parsers VC has collected 19 articles mentioning Time BioVentures, among them “AdvanCell Closes US $315M in Series D Funding” (Jul 15, 2026) and “Commons Clinic: $26 Million Series B Raised For Wholebody Multi-Specialty Care Platform” (Jun 23, 2025).
Is Time BioVentures still active?
Yes, Time BioVentures is active; its latest activity on Parsers VC dates from Jul 16, 2026.